Second, not all the cancer cells necessarily have the structure the T-cells can recognize ... Martins et al, Enhancing anti-EGFRvIII CAR T cell therapy against glioblastoma with a paracrine ...

Second, not all the cancer cells necessarily have the structure the T-cells can recognize and attack ... In this work, we engineer a CAR T cell against epidermal growth factor receptor variant III ...

Second, not all the cancer cells necessarily have the structure the T-cells can recognize and attack. And third, solid tumors in human tissue have a microenvironment that fends off immune system ...

Expert Rev Mol Diagn. 2009;9(7):709-720. Furthermore, loss-of-function mutations in the p53 protein are found in more than 65% of low-grade astroctytomas, anaplastic astrocytomas and secondary GBM ...

In a recent Phase II multicenter trial of EGFRvIII-targeted vaccination in 18 patients with GBM who received the standard therapy of gross total resection followed by RT and concurrent TMZ ...

We focus on breast cancer in a very broad sense and build our projects on the strong epidemiologic tradition and infrastructure of our home department. We collaborate with several strong research ...

David is comprehensively experienced in many facets of financial and legal research and publishing. As an Investopedia fact checker since 2020, he has validated over 1,100 articles on a wide range ...